{"cmr":"ca-cm-kg/CSE/RHEL","since":null,"total":21,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-11-03","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/322278/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Ships-PEX010-to-the-University-of-Southern-California-for-the-Expanded-Mindfulness-Assisted-Psychedelic-Therapy-Trial","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GAlmSjV-lqIeVPUFlRjMJgai8zlNQMqy3MK5cAbrK-mpq5B3qJ5hzQTq4DdsG843h0Heid9th94QncSH1WNhAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-11-03","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hvkbkiNa5lqEasQv88ojtsNIU8Fjgz7OOdvbSnsoGfgyvF17oKuRV-fQhR8QNpW0_VTu4Yxh13nnX3IAysuKBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-11-02","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1OugKN7Q1y9lA0X0hfHEwFfEkFHb32Ake-HvoE5Lzu-M6CzJnUNEw6S_Dz70wYq7ndph_nOIKkn2AvxKMoJWCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-11-02","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing?lang=fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ttsZJK05A_Tr6pzg9LhsLtrmf7lxCegg2ZoPyjClDB14crloRjbAyMIubRh5sa87aZfTCxSj-qljQQ4HSzcKBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-29","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321406/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Agreement-to-Supply-PEX010-to-Linkoping-University-for-PsiloSAD-Trial-in-Social-Anxiety-Disorder","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AIRDsnewOU4Agt9Kej_epA_RLEwa3ncoU-j9GxRqI9kwo2XgCgcM1mqvnzSQNducMerZTlnMKou-SaFazplJBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-28","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321406/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Agreement-to-Supply-PEX010-to-Linkoping-University-for-PsiloSAD-Trial-in-Social-Anxiety-Disorder","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PDW-8GHM_b56a31rZJTyJBgd9ozark3R3wFRve-8VdlPH_Kz3o8QFYmGo-WJiVt-7p7iHwe_JBtUQgK0qxLpCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-28","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321406/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Agreement-to-Supply-PEX010-to-Linkoping-University-for-PsiloSAD-Trial-in-Social-Anxiety-Disorder?lang=fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7fqc2E9UxqwVWWiHa5YSHo0DOUg2kvIA-SYFTB329B5NZ7iI8gbf34GTI3bvOruHe5TuVxT6CmxrBaqbTgauDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-22","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/319354/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-to-Supply-Belgiums-First-Psilocybin-Compassionate-Use-Program-to-Help-Open-the-Door-to-Patient-Access-for-TreatmentResistant-Depression","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"10OZ3suRS3m8dH0rdaCJWLJshbocIVKMFRV-4HUw-f53HgNJcCXnP-UqmZILr1mLXezOYpmsdM1XyCh9subbBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-16","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/319354/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-to-Supply-Belgiums-First-Psilocybin-Compassionate-Use-Program-to-Help-Open-the-Door-to-Patient-Access-for-TreatmentResistant-Depression","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pJJmhtZKfAYXxDm-7rxrVudKoApccd0gr6vF1mnXvcWuD_-L_ERHjZTLcDqVx2SkLIupZiWHQah8dfvZZZdbCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-14","event_type":"newswire_release","title":"Rhelion Life Sciences Reappoints Dr. Robin Carhart-Harris as Scientific Advisor","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/318914/Rhelion-Life-Sciences-Reappoints-Dr.-Robin-CarhartHarris-as-Scientific-Advisor","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NDWoIMEhjtP24Ap5tBXyXPfaHGlhWK4vejkjw1yWa12iY4fzydKkC1heAddXoXzZ_HDTqBUMaM5f9lXn2wkjAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-08","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/318082/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Licence-Agreement-with-the-University-of-California-San-Francisco-for-a-Phase-2-Trial-of-Psilocybin-in-Methamphetamine-Use-Disorder-Among-People-with-HIV?lang=fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"39Nt9rAzGZ7bMWBwR7bQTHroU5fONVSXlNNPN9mriU9xuOeRy79bLjpp1oOc_50El4_xh8QHakcDWY5XAlkvCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-10-08","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/318082/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Licence-Agreement-with-the-University-of-California-San-Francisco-for-a-Phase-2-Trial-of-Psilocybin-in-Methamphetamine-Use-Disorder-Among-People-with-HIV","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pvP2Cxvg0hu24YaqcSYEEDOARSu-gafmW_nV8jIcEVOt_LkIbpZjURnavM1tj40MEb-hzpZQFBu8DxIjbi2BBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-25","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/316036/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Expands-Supply-Agreement-with-the-University-of-ChietiPescara-for-PEX010-in-the-TEMPO-Clinical-Trial-of-Psilocybin-for-TreatmentResistant-Depression-in-Italy","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JkDcDzAAlrVZ2TCcUBIh2u1wyTOjzVZS9QiZ4hHDKIDIVSZ1u-GOAQVk9A7d41ky-Nd2r5ntNTyNLIHFY8t9Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-22","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New Canadian Patent, Extending the Broadest Natural Psilocybin Patent Estate","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/315405/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Issued-New-Canadian-Patent-Extending-the-Broadest-Natural-Psilocybin-Patent-Estate","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BO9PMBEoa0Ws9H-aGW6IN5cAxniEP7aOKSnFo-EpQolVNw9sZvZSbJpybNZD8ZOdKhiT5jIX4X05rdaMeGHSAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-21","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Microdose Psilocybin in Palliative Care","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/315164/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Delivers-PEX010-to-Bruyere-Health-Research-Institutes-Phase-3-Trial-of-Microdose-Psilocybin-in-Palliative-Care","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zQp2I_5EQ2u0aHsr2OpgOYk0az09KkRP-r4R0x5z_4Ike9ODYFDpapY9gsLYgjdEZ-t8hu7URpnjx4QdunGwAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-17","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/314769/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Supply-and-Licensing-Agreement-with-the-Centre-for-Human-Drug-Research-for-PEX010-in-a-Study-of-Low-and-Medium-Dose-Psilocybin","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lmUiD2uC-P-lEZe4tUrquRTFEw49Xk3hwDJzKRyDKMgvuFhqFribSxDYGHgtzU75VPxi_njds2sIz4Y2BPIVDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-15","event_type":"newswire_release","title":"Rhelion Life Sciences Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the University of Southern California for PEX010 in a Trial for Psilocybin-Assisted Mindfulness Therapy","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/314398/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Supply-and-Licensing-Agreement-with-the-University-of-Southern-California-for-PEX010-in-a-Trial-for-PsilocybinAssisted-Mindfulness-Therapy","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qlguzmxeS5jf0WTfAXE-zn8N77nR3Ny_T1JooOmcyM6fgYQF_A37MlxDFNZ3HpnJ5yqDhhStkHBGk2to3pVbDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-14","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/314170/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-to-Deliver-Oral-Comments-at-FDA-Public-Hearing-on-the-Potential-Future-Therapeutic-Use-of-Psychedelic-Drugs?lang=fr","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aGoPUhxuQlQxt5He2zApJ7zxcEh7EtZgzwA2e12jIeu0WBcPwYnNyCS7rdyKh_UvjxGdV4Pi0tIJg9KhmhZKDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-14","event_type":"newswire_release","title":"Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/314170/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-to-Deliver-Oral-Comments-at-FDA-Public-Hearing-on-the-Potential-Future-Therapeutic-Use-of-Psychedelic-Drugs","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cS0dF85SeqMQGn33BGW9FGY2N8Xfsci87uKUjfOWLn5-U81ozdGufsX8SsVZmrYZyOwC2r_tMT_p4PtmuZeSCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-09-10","event_type":"newswire_release","title":"Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/313819/Rhelion-Life-Sciences-Announces-Filament-Health-is-Planning-a-Stability-Program-for-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Lv0A45_gGmaLDpwfxGg63aI18fOLJEP1xKWxqkl_H2w8agGNV3U8k6_CAqhqLSo6bc1tXgjyXyVW2QnoH1sbBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/RHEL","date":"2026-07-30","event_type":"corporate_action","title":"2026-0738 - Name and Symbol Change - Red Light Holland Corp. (TRIP)","source":"CSE bulletin","url":"https://thecse.com/bulletin/2026-0738-name-and-symbol-change-red-light-holland-corp-trip/","read_by":"thecse.com bulletins API","detail":"Name and Symbol Change","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7Uetko46gpFKQQ8uFQMjsEijU9I50usdY-GGNT1SCIRsFOsQI1nvMcMnJpUrZmOg3BAt1qBc3TLMiyOvOuAcCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}